Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 8:29 PM View:  | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 07-Oct-24 | Planned Private Option Sale | 5,000 | $109.27 | $546,352.00 | (15%) 33.62K to 28.62K | |
| 08-Oct-24 8:32 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 07-Oct-24 | Private Sale (Planned) | 7,098 | $109.21 | $775,154.00 | (< 1%) 734.48K to 727.38K | |
| 08-Oct-24 8:29 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 07-Oct-24 | Option Exercise | 5,000 | $21.41 | $107,050.00 | 17% 28.62K to 33.62K | 6% |
| 03-Oct-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Planned Option Sale | 40,000 | $114.25 | $4,570,080.00 | (5%) 789.48K to 749.48K | |
| 03-Oct-24 4:16 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Option Exercise | 8,000 | $2.42 | $19,360.00 | 4% 200.65K to 208.65K | |
| 03-Oct-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Option Exercise | 40,000 | $5.35 | $214,000.00 | 5% 749.48K to 789.48K | |
| 03-Oct-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Sale (Planned) | 15,000 | $114.25 | $1,713,780.00 | (2%) 749.48K to 734.48K | |
| 03-Oct-24 4:16 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Planned Option Sale | 8,000 | $114.24 | $913,918.00 | (4%) 208.65K to 200.65K | |
| 19-Sep-24 5:48 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Sep-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 9% 90.38K to 98.38K | |
| 19-Sep-24 5:48 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Sep-24 | Planned Option Sale | 8,000 | $115.94 | $927,551.00 | (8%) 98.38K to 90.38K | |
| 18-Sep-24 4:24 PM View: | Loxam Teri Director | Vaxcyte, Inc. (PCVX) | 17-Sep-24 | Option Exercise | 6,250 | $22.70 | $141,875.00 | 87% 7.17K to 13.43K | < 1% |
| 18-Sep-24 4:24 PM View: | Loxam Teri Director | Vaxcyte, Inc. (PCVX) | 17-Sep-24 | Planned Private Option Sale | 6,250 | $116.28 | $726,731.00 | (47%) 13.43K to 7.17K | |
| 05-Sep-24 5:15 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Option Exercise | 5,000 | $25.92 | $129,600.00 | 39% 12.72K to 17.72K | |
| 05-Sep-24 5:13 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 2,203 | $110.15 | $242,660.00 | (7%) 32.49K to 30.29K | |
| 05-Sep-24 5:13 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Planned Option Sale | 1,667 | $112.11 | $186,880.00 | (6%) 30.29K to 28.62K | |
| 05-Sep-24 5:18 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 6,337 | $110.15 | $698,021.00 | (7%) 96.72K to 90.38K | |
| 05-Sep-24 5:15 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Planned Option Sale | 5,000 | $107.67 | $538,350.00 | (30%) 16.58K to 11.58K | |
| 05-Sep-24 5:19 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 5,545 | $110.15 | $610,782.00 | (3%) 217.5K to 211.96K | |
| 05-Sep-24 5:19 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Planned Option Sale | 10,000 | $111.93 | $1,119,250.00 | (5%) 211.96K to 201.96K | |
| 05-Sep-24 5:13 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Option Exercise | 1,667 | $21.41 | $35,690.50 | 5% 30.83K to 32.49K | 6% |
| 05-Sep-24 5:18 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 13,669 | $110.15 | $1,505,640.00 | (2%) 763.15K to 749.48K | |
| 05-Sep-24 5:15 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 1,145 | $110.15 | $126,122.00 | (6%) 17.72K to 16.58K | |
| 05-Sep-24 5:19 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Option Exercise | 10,000 | $2.42 | $24,200.00 | 5% 207.5K to 217.5K | |
| 26-Aug-24 4:58 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Aug-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 763.15K to 778.15K | |
| 26-Aug-24 4:58 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Aug-24 | Planned Option Sale | 15,000 | $78.98 | $1,184,770.00 | (2%) 778.15K to 763.15K | |
| 20-Aug-24 4:49 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 19-Aug-24 | Planned Option Sale | 8,000 | $78.58 | $628,650.00 | (8%) 104.72K to 96.72K | |
| 20-Aug-24 4:49 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 19-Aug-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 8% 96.72K to 104.72K | |
| 05-Aug-24 4:10 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Aug-24 | Private Sale (Planned) | 3,000 | $78.84 | $236,527.00 | (1%) 210.5K to 207.5K | |
| 05-Aug-24 4:06 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Aug-24 | Option Exercise | 1,667 | $21.41 | $35,690.50 | 5% 30.83K to 32.49K | 6% |
| 05-Aug-24 4:08 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Aug-24 | Private Sale (Planned) | 2,616 | $78.79 | $206,122.00 | (< 1%) 765.76K to 763.15K | |
| 05-Aug-24 4:06 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Aug-24 | Planned Private Option Sale | 1,667 | $78.85 | $131,449.00 | (5%) 32.49K to 30.83K | |
| 24-Jul-24 5:44 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Jul-24 | Planned Option Sale | 15,000 | $84.26 | $1,263,910.00 | (2%) 780.76K to 765.76K | |
| 24-Jul-24 5:44 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Jul-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 765.76K to 780.76K | |
| 22-Jul-24 4:03 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jul-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 8% 96.72K to 104.72K | |
| 22-Jul-24 4:03 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jul-24 | Planned Option Sale | 8,000 | $81.17 | $649,325.00 | (8%) 104.72K to 96.72K | |
| 17-Jul-24 4:03 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 16-Jul-24 | Planned Option Sale | 5,000 | $85.00 | $425,000.00 | (28%) 17.72K to 12.72K | |
| 17-Jul-24 4:03 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 16-Jul-24 | Option Exercise | 5,000 | $25.92 | $129,600.00 | 39% 12.72K to 17.72K | |
| 09-Jul-24 5:15 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 08-Jul-24 | Planned Option Sale | 5,000 | $80.00 | $400,000.00 | (28%) 17.72K to 12.72K | |
| 09-Jul-24 5:15 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 08-Jul-24 | Option Exercise | 5,000 | $25.92 | $129,600.00 | 39% 12.72K to 17.72K | |
| 25-Jun-24 4:43 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 24-Jun-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 768.38K to 783.38K | |
| 25-Jun-24 4:43 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 24-Jun-24 | Planned Option Sale | 15,000 | $75.64 | $1,134,580.00 | (2%) 783.38K to 768.38K | |
| 20-Jun-24 8:30 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jun-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 8% 96.72K to 104.72K | |
| 20-Jun-24 8:30 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jun-24 | Planned Option Sale | 8,000 | $71.92 | $575,375.00 | (8%) 104.72K to 96.72K | |
| 10-Jun-24 4:13 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 07-Jun-24 | Payment of Exercise | 335 | $70.97 | $23,775.00 | (1%) 31.16K to 30.83K | |
| 10-Jun-24 4:09 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 28% 5.63K to 7.17K | |
| 10-Jun-24 4:10 PM View: | Gilbert Halley E Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 28% 5.63K to 7.17K | |
| 10-Jun-24 4:08 PM View: | Drapeau Anne S Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 28% 5.63K to 7.17K | |
| 10-Jun-24 4:12 PM View: | Lee Jacks Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 100% 0 to 1.55K | |
| 10-Jun-24 4:11 PM View: | Loxam Teri Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 28% 5.63K to 7.17K | |
| 10-Jun-24 4:05 PM View: | Paya Carlos V Director | Vaxcyte, Inc. (PCVX) | 06-Jun-24 | Grant | 1,550 | -- | -- | 28% 5.63K to 7.17K |
